|
Tapazoglou, E; Kish, J; Ensley, J et al. (1988) Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress report. Am J Clin Oncol 11:474-8
|
|
Pazdur, R; Samson, M K; Baker, L H (1987) Fludarabine phosphate. Phase II evaluation in advanced soft-tissue sarcomas. Am J Clin Oncol 10:341-3
|
|
Pazdur, R; Samson, M K; Baker, L H (1987) CBDCA: phase II evaluation in advanced colorectal carcinoma. Am J Clin Oncol 10:136-8
|
|
Martino, S; Decker, D A; Hynes, H E et al. (1987) Phase II evaluation of aclacinomycin-A in advanced ovarian carcinoma. Invest New Drugs 5:373-4
|
|
Al-Sarraf, M; Metch, B; Kish, J et al. (1987) Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study. Cancer Treat Rep 71:723-6
|
|
Pazdur, R; Samson, M K; Baker, L H (1987) Aclacinomycin A. Phase II evaluation in bronchogenic squamous-cell carcinoma. Am J Clin Oncol 10:234-6
|
|
Pazdur, R; Samson, M K; Baker, L H (1987) Aclacinomycin A. Phase II evaluation in advanced soft tissue sarcoma. Am J Clin Oncol 10:237-9
|
|
Decker, D A; Kinzie, J; Evans, R et al. (1987) Pilot study of combination 5-fluorouracil, cisdiamminedichloroplatinum II, and radiation therapy for grade III and IV astrocytomas. Am J Clin Oncol 10:444-7
|
|
Decker, D A; Kish, J; Al-Sarraf, M et al. (1986) Phase II clinical evaluation of AZQ in renal cell carcinoma. Am J Clin Oncol 9:126-8
|
|
Kish, J A; Ensley, J; Al-Sarraf, M (1986) Phase II evaluation of diaziquone in recurrent head and neck cancer. Cancer Treat Rep 70:671-2
|
Showing the most recent 10 out of 12 publications
